Back to discover
Disease
Eclampsia
Late-stage therapeutic developmentEmerging research
1
Publications
19
Clinical trials
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2022-11-15BMC medicine
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 3 clinical trials expected to report results, the earliest in Q1 2027.
Major developments
Upcoming trial readoutHigh impact
Results expected Q1 20272026-09-22
Upcoming trial readoutImportant
Results expected Q3 20282026-05-07
Clinical MilestonesViewHide
Results expected
- 2026-09-22Treatment With Aspirin After Preeclampsia: TAP TrialResults expected Q1 2027
- 2026-05-07Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes in Nulliparous Women After Assisted Reproductive Technology. APPARTResults expected Q3 2028
- 2026-01-20APPLE: Aspirin to Prevent Pregnancy Loss and PreeclampsiaResults expected Q2 2029
Recently completed
- 2026-03-30A Prospective, Randomized Controlled Study to Evaluate the Effects of Daily Low Dose Aspirin in Pregnant Women With Sickle Cell Disease When Initiated at the First Trimester Versus the Second Trimester of the Gestational PeriodPrimary completion
- 2026-02-08Role of Vitamin D in Prevention of Preeclampsia Recurrence in Pregnant Women With Previous History of Preeclampsia: A Randomized Controlled TrialPrimary completion
- 2025-11-12Frequency of Recurrence of Seizures With Intravenous Versus Intramuscular Magnesium Sulphate in Women With EclampsiaCompleted
Activity timeline6
- 2026-09-22ClinicalTreatment With Aspirin After Preeclampsia: TAP TrialResults expected Q1 2027
- 2026-05-07ClinicalAspirin for the Prevention of Preeclampsia and Pregnancy Outcomes in Nulliparous Women After Assisted Reproductive Technology. APPARTResults expected Q3 2028
- 2026-03-30ClinicalA Prospective, Randomized Controlled Study to Evaluate the Effects of Daily Low Dose Aspirin in Pregnant Women With Sickle Cell Disease When Initiated at the First Trimester Versus the Second Trimester of the Gestational PeriodPrimary completion
- 2026-02-08ClinicalRole of Vitamin D in Prevention of Preeclampsia Recurrence in Pregnant Women With Previous History of Preeclampsia: A Randomized Controlled TrialPrimary completion
- 2026-01-20ClinicalAPPLE: Aspirin to Prevent Pregnancy Loss and PreeclampsiaResults expected Q2 2029
- 2025-11-12ClinicalFrequency of Recurrence of Seizures With Intravenous Versus Intramuscular Magnesium Sulphate in Women With EclampsiaCompleted
Clinical trials
The current development programme across all trial phases.
Clinical programme
19
6
15
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes3
- Eclampsia1
- Gastrointestinal Microbiome1
- Pre-Eclampsia1
Leading journals1
- BMC medicine1
Leading researchers8
- Chen G1
- Fan D1
- Gou X1
- Guo L1
- Guo X1
- Li P1
- Lin D1
- Liu Z1
Affiliations (unnormalised)3
- Affiliated Foshan Maternity & Child Healthcare Hospital1
- Foshan Fetal Medicine Research Institute1
- School of Public Health1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.